tranexamic acid

Poland

Drugs containing this active substance

  • DEPORIUM

    The medicine is used to stop or limit unwanted bleeding. It may be used for the prevention and reduction of bleeding in cases such as: after prostate or bladder surgery, during heavy menstruation, after cervical surgery, during tooth extraction in people with hemophilia, and in the case of hereditary angioedema.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 1000 mg

    ATC: B02AA02

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used to treat heavy and prolonged menstrual bleeding in women with regular cycles.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding caused by the process that inhibits blood clotting (fibrinolysis). It may be used, among other things, for heavy menstrual bleeding, gastrointestinal bleeding, after urinary tract, heart, or abdominal surgeries, gynecological procedures, and ear, nose, and throat procedures, as well as for bleeding caused by clot-dissolving drugs.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: Delpharm Dijon Sanofi Winthrop Industry

  • The medicine is used to inhibit bleeding, such as: genital bleeding, gastrointestinal bleeding, hematuria (e.g., due to kidney stones or tumors), and bleeding related to surgical procedures (e.g., tonsillectomy).

    Form: solution, oral

    Active substance Dosage
    tranexamic acid 1000 mg

    ATC: B02AA02

    Manufacturer: Cooperation Pharmaceutique Francaise Unither Liquid Manufacturing

  • The medicine is used to inhibit bleeding, such as: genital bleeding (e.g., caused by hormonal disorders or trauma), gastrointestinal bleeding, hematuria (e.g., due to kidney stones or tumors), and bleeding related to surgical procedures (e.g., tonsillectomy).

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: Fidelio Healthcare Limburg GmbH Opella Healthcare Poland Limited Liability Company Branch in Rzeszów

  • The medicine is used to reduce heavy menstrual bleeding in women over 15 years of age who have regular menstrual cycles.

    Form: granules, coated in sachet

    Active substance Dosage
    tranexamic acid 1000 mg

    ATC: B02AA02

    Manufacturer: Inpharmasci

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding. It may be used for heavy menstruation, gastrointestinal bleeding, urinary tract disorders after surgery, as well as during or after surgical procedures (e.g., ear, nose, throat, heart, abdominal, or gynecological surgeries) and for bleeding caused by thrombolytic drugs.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding caused by processes that inhibit blood clotting. It may be used, among others, for heavy menstruation, gastrointestinal bleeding, surgical procedures (e.g., ear, nose, throat, heart, abdominal, gynecological), and bleeding caused by blood-thinning medications.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Medochemie Ltd.

  • The medicinal product is used in adults and children over 1 year of age to prevent and treat bleeding caused by processes that inhibit blood clotting. It may be used, among others, for heavy menstruation, gastrointestinal bleeding, surgical procedures (urinary tract, ear, nose, throat, heart, abdomen, gynecology), and after the administration of thrombolytic drugs.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Viatris Italia S.r.l.

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding. It may be used for heavy menstrual bleeding, gastrointestinal bleeding, urinary tract disorders after surgery, surgical procedures (including ear, nose, throat, heart, abdominal, and gynecological surgeries), and bleeding following thrombolytic therapy.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: APL Swift Services (Malta) Ltd., Generis Farmacêutica, S.A.

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding caused by processes that inhibit blood clotting. It may be used, among other things, for heavy menstrual bleeding, gastrointestinal bleeding, urinary tract disorders after surgery, during surgical procedures (e.g., ear, nose, throat, heart, abdominal, or gynecological surgery), and after the use of thrombolytic drugs.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Viatris Italia S.r.l.

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding caused by processes that inhibit blood clotting. It may be used, among others, for heavy menstrual bleeding, gastrointestinal bleeding, urinary tract disorders after surgery, and during or after surgical procedures (e.g., in the ear, nose, throat, heart, abdomen, or gynecological procedures).

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Bioindustria Laboratorio Italiano Medicinali S.p.A.

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding. It may be used, among other things, for heavy menstrual bleeding, gastrointestinal bleeding, surgical procedures (e.g., in the ear, nose, throat, heart, abdomen, or gynecological procedures), and bleeding following thrombolytic treatment.

    Form: solution for injection for infusion

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Health-Med spółka z ograniczoną odpowiedzialnością sp.k.

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding caused by the process that inhibits blood clotting (fibrinolysis). It may be used, among other things, for heavy menstruation, gastrointestinal bleeding, surgical procedures (e.g., ear, nose, throat, heart, abdominal, gynecological), and bleeding following thrombolytic drugs.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: Viatris Italia S.r.l.

  • The medicine is used to stop or limit unwanted bleeding. It may be used for prophylaxis or to reduce bleeding in various conditions, such as: after surgery (bladder, prostate, cervix), during heavy menstruation, severe nosebleeds, intraocular bleeding, tooth extractions in people with hemophilia, and in the case of a hereditary condition called angioedema.

    Form: tablets, film-coated

    Active substance Dosage
    tranexamic acid 500 mg

    ATC: B02AA02

    Manufacturer: MIAS Pharma Ltd, SGS Pharma Hungary Kft.

  • The medicine is used in adults and children over 1 year of age to prevent and treat bleeding. It may be helpful in cases of heavy menstruation, gastrointestinal bleeding, urinary tract disorders after surgery, procedures involving the ear, nose, throat, heart, abdomen, or gynecological procedures, as well as bleeding caused by blood-thinning medications.

    Form: solution for injection

    Active substance Dosage
    tranexamic acid 100 mg/ml

    ATC: B02AA02

    Manufacturer: MIAS Pharma Ltd, Tillomed Malta Limited